Created in 2017, OVD Development owns the Intellectual Property related to a new approach to viscoelastic medium (OVD) for ophthalmology surgery. The aim for this investment is to finish the CE marking process and launch production & sales with distribution partners to target the global market.
OVD Development owns IP rights for fluorescent products for ophthalmic surgery, with applications for patents for Europe, the US and Canada filed in 2015. The product that has been developed is a FLUON line of fluorescent viscoelastic mediums, for ophthalmic surgery, which can reduce the risk of increase of post-op intra-ocular pressure (the source of most complications) and aims to make operations faster and more comfortable for surgeons.
FLUON has the ability to replace surgeons usual products without disruption or limited investment.
In a global market, we estimate to be worth $560 million with an expected 11.6% average annual growth until 2027, We estimate that FLUON products could cover 95% of OVD's medical indications and usage.
With CE marking of OVD, we believe we could gain access to the European market which we estimate to be more than 35% of the global market.
OVD Development benefits from the founder's relationships with leading ophthalmologists, distributors, and clinics worldwide. We aim to launch FLUON products, with CE marking, in the third quarter of 2019 across 15 countries worldwide.